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Polycystic ovary syndrome (PCOS) is a leading cause of infertility and is characterized by 
hyperandrogenemia, polycystic ovaries and irregular menses. The underlying cause of PCOS is 
unknown but may involve effects of androgens during prenatal development. Women with 
hyperandrogenemia during pregnancy have daughters at higher risk of developing PCOS as 
adults. Androgens may interfere with development of neuronal networks important for regulating 
reproduction. Gonadotropin-releasing hormone (GnRH) neurons are the final common pathway 
for the central regulation of fertility. Pulsatile GnRH release signals the pituitary to release 
luteinizing hormone (LH) which stimulates ovarian hormone production. In most women with 
PCOS, GnRH/LH pulse frequency is persistently elevated, contributing to excess ovarian 
androgen production and irregular cycles. Clinical studies have revealed that obese peripubertal 
girls with hyperandrogenemia have elevated LH pulse frequency suggesting that neuroendocrine 
dysfunction seen in adult women with PCOS emerges during prepubertal development.  
 
Prenatal androgen (PNA) exposure has been used in experimental models to replicate aspects of 
PCOS in adulthood. GnRH neurons from adult PNA mice have increased firing rate and 
increased excitatory GABAergic transmission. GABAergic afferents are a major source of input 
to GnRH neurons but neither the typical pattern of when GABAergic transmission develops nor 
when changes emerge with PNA are understood. We used whole-cell voltage clamp recordings 
to examine GABAergic postsynaptic currents (PSCs) in GnRH neurons from control and PNA 
 viii 
mice during postnatal development in both females and males. 1-wk old female and male mice 
had low frequencies of GABAergic transmission that increased to adult levels by 3- and 4-wks of 
age, respectively. This increase was more robust in PNA mice of both sexes. This difference 
persisted into adulthood in females but not males. Differences in PSC frequency were activity 
independent, consistent with changes in synaptic connectivity rather than presynaptic activation. 
In PNA females, increased GABAergic transmission occurs concomitantly with decreased 
GnRH neuron firing at 3-wks of age. The percentage of cells firing and membrane potential 
depolarization in response to GABA was decreased in PNA females at 3-wks of age but not 
adults. This difference was not due to altered chloride homeostasis of GnRH neurons as the 
equilibrium potential of the GABAAR-mediated current was not altered by PNA at 3-wks of age. 
Our work shows that prenatal androgen exposure programs neuroendocrine changes that may 
contribute to adult reproductive dysfunction. Increasing numbers of pre-adolescents are at risk 
for developing hyperandrogenemia in association with childhood obesity, highlighting our need 
for greater understanding of how excess androgen exposure affects developing brain circuits. 
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Chapter 1 Introduction 
 
Polycystic ovary syndrome [PCOS] is a leading cause of infertility in women around the world 
(Goodarzi et al., 2011). In addition to infertility, PCOS has profound life-long health 
implications including an association with metabolic syndrome and increased risk of 
hospitalization for heart disease, diabetes, stroke, cancer and mental health disorders (Hart and 
Doherty, 2015). In the US, approximately 8% of women of reproductive age are affected by 
PCOS as defined by the classic 1990 NIH diagnostic criteria of irregular or absent menstrual 
cycles and hyperandrogenemia (Zawadski and Dunaif, 1992; Bulletins--Gynecology, 2009). 
These diagnostic criteria were expanded in 2003 to include women who met any two of the 
following three features: 1) irregular or absent menstrual cycles, 2) hyperandrogenemia, or 3) 
polycystic ovaries (Rotterdam, 2004). This introduction will primarily focus on the classic NIH-
defined PCOS phenotype as it most clearly relates to neuroendocrine features of PCOS that will 
be examined in the following work. The absence of unified diagnostic criteria reflects the broad 
range of clinical presentations of PCOS and has impeded discovery into the basic mechanisms 
and therapeutic interventions for the disease.  
 
Despite the high prevalence and impact of PCOS, the etiology and mechanism(s) of disease 
progression are still incompletely understood. It has long been recognized that PCOS tends to 
run in families, suggesting that a degree of genetic susceptibility and/or environmental factors 
may contribute to PCOS pathology (Kahsar-Miller et al., 2001). Genome wide association 
 2 
studies have identified several loci of genetic susceptibility however the predictive power of 
these variants is low, indicating that genetic heritability alone does not account for the familial 
clustering of PCOS (Brower et al., 2015). Androgen exposure during development has been 
proposed as an environmental risk factor for PCOS. Women with congenital adrenal hyperplasia 
(CAH) have very high levels of androgens and their daughters are at high risk for developing 
PCOS as adults (Hague et al., 1990). Women with PCOS also have elevated androgens during 
pregnancy and their daughters have elevated testosterone levels during later stages of pubertal 
development and are at increased risk of developing PCOS themselves (Sir-Petermann et al., 
2002; Kent et al., 2008; Maliqueo et al., 2009; Sir-Petermann et al., 2009). Obesity during 
prepubertal development is associated with elevated androgen levels, which may promote the 
onset of PCOS in these girls (McCartney et al., 2006; Knudsen et al., 2010). 
 
The central neuroendocrine system that helps regulate reproductive function is persistently 
overactive in most adult women with PCOS (Rebar et al., 1976). Clinical studies have revealed 
the presence of neuroendocrine features of adult PCOS in hyperandrogenemic prepubertal girls 
(Chhabra et al., 2005; Blank et al., 2009). The outward clinical markers of PCOS typically 
appear during puberty, suggesting that underlying mechanisms of PCOS arise prior to pubertal 
maturation (Franks, 2008; Knudsen et al., 2010). Neuroendocrine changes during prepubertal 
development likely have important implications for adult reproductive function and may play a 
role in the etiology of PCOS. This introduction will review aspects of the typical neuroendocrine 
regulation of reproductive function, how changes within this system may contribute to PCOS 
pathology and the role of changes during pre- and peripubertal development in the progression of 
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PCOS. This introduction will be limited to studies published before the start of my PhD work in 
2014.  
 
Neuroendocrine regulation of reproductive function (HPG axis) 
In vertebrates, reproductive function is regulated through interactions of the hypothalamus, 
pituitary and gonads. Gonadotropin-releasing hormone (GnRH) neurons in the hypothalamus are 
the final common pathway for the central regulation of reproduction. GnRH neurons extend 
processes to the median eminence and release GnRH close to the hypophyseal portal capillaries 
leading to the anterior pituitary. GnRH is released in discrete pulses (Carmel et al., 1976; 
Moenter et al., 1992). Gonadotropes in the anterior pituitary are sensitive to the frequency of 
GnRH release; high and low frequency GnRH pulses signal gonadotropes to preferentially 
synthesize and release the gonadotropin hormones luteinizing hormone (LH) and follicle-
stimulating hormone (FSH), respectively (Wildt et al., 1981; Haisenleder et al., 1991). LH and 
FSH promote gonadal steroidogenesis and ovarian follicle maturation (Bousfield, 2006). 
Pulsatile GnRH is both necessary and sufficient for fertility; pituitary gonadotropes become 
refractory to continuous non-pulsatile GnRH (Belchetz et al., 1978) and administration of 
pulsatile GnRH can restore menstrual cycles in individuals with hypogonadotropic 
hypogonadism (Martin et al., 1990). Pulses of GnRH in portal blood are closely associated with 
pulses of LH in the peripheral circulation, allowing LH to be used as a convenient bioassay for 
the pattern of GnRH release (Clarke and Cummins, 1982).  
 
Shifts in the pattern of GnRH release regulate reproductive cycles. GnRH pulse frequency and 
the gonadotropin response to GnRH are in turn modulated by ovarian steroid hormone feedback 
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to the hypothalamus and pituitary (Clarke and Cummins, 1984; Karsch, 1987; Shaw et al., 2010). 
During most of the length of the reproductive cycle, estradiol has a negative feedback effect on 
GnRH/LH pulses (Reame et al., 1984; Chongthammakun and Terasawa, 1993). Estradiol levels 
peak during the late follicular phase (proestrus in rodents). During this period, the central effect 
of estradiol feedback undergoes a switch from negative to positive (Filicori et al., 1986; Evans et 
al., 1994; Czieselsky et al., 2016). These changes lead to increased GnRH neuron firing rate and 
a surge of GnRH release (Sarkar et al., 1976; Moenter et al., 1990; Christian et al., 2005; 
Glanowska et al., 2012). The GnRH surge induces an LH surge which triggers ovulation (Docke 
and Dorner, 1965). Following ovulation, progesterone is secreted by the resulting corpus luteum 
and is associated with a marked decrease in LH pulse frequency and amplitude (Filicori et al., 
1986; Rossmanith et al., 1990). 
 
Progesterone feedback is an important modulator of GnRH/LH pulse frequency. Progesterone 
treatment of naturally cycling women resulted in lowered LH pulse frequency and decreased 
mean plasma LH levels compared to untreated women at all phases of the menstrual cycle 
(Soules et al., 1984). In another study of naturally cycling women, treatment with estradiol in 
addition to progesterone was necessary to prevent the increase in LH pulse frequency from the 
luteal to follicular phase (Nippoldt et al., 1989). Estradiol regulates progesterone receptor 
expression in the hypothalamus and thus likely helps enable progesterone negative feedback 
(Romano et al., 1989). The relative contributions of estradiol and progesterone feedback effects 
on LH pulses were assessed by treating ovariectomized rats with implants of either estradiol, 
progesterone or both (Leipheimer et al., 1984). Ovariectomy (OVX) resulted in a sharp increase 
in pulsatile LH that was suppressed by progesterone alone but was unaltered by estradiol 
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treatment alone. Progesterone treatment in combination with estradiol had an even more robust 
suppression of LH pulse frequency and amplitude. Interestingly, this effect may be mediated, at 
least in part, by the hypothalamus as the pituitary response to GnRH was not different between 
OVX rats with or without progesterone. Similar effects of combination progesterone and 
estradiol treatment on LH pulses have been observed in OVX sheep, further highlighting the 
synergistic role of estradiol to promote central sensitivity to progesterone negative feedback 
(Goodman et al., 1981).  
 
Neuroendocrine dysfunction in polycystic ovary syndrome  
In most women with PCOS, LH pulse frequency is persistently elevated compared to typically 
cycling women (Rebar et al., 1976). This likely reflects elevated GnRH pulse frequency as the 
pulse frequency of LH mirrors the pattern of episodic GnRH release (Moenter et al., 1992). 
Persistently elevated GnRH pulse frequency leads to an increased LH to FSH ratio that is 
characteristic of PCOS. This altered gonadotropin signaling, together with changes in ovarian 
physiology, contribute to elevated androgen levels in PCOS women (Goodarzi et al., 2011; 
McCartney and Marshall, 2016). First, thecal cells from polycystic ovaries are primed to secrete 
excess androgens in response to LH (Gilling-Smith et al., 1994). Second, the altered 
gonadotropin ratio results in immature follicles that are deficient in aromatase, further 
exacerbating hyperandrogenemia (Taylor et al., 1997). Treatment of women with PCOS with a 
long-acting GnRH agonist lowered their serum LH and this appears to normalize their serum 
androgen levels, suggesting that high LH pulse frequency drives ovarian hyperandrogenemia in 
these women (Chang et al., 1983). Furthermore, GnRH antagonists can reduce testosterone levels 
in women with PCOS, indicating that abnormal gonadotropin secretion in PCOS is likely to be at 
 6 
least in part due to hypothalamic dysfunction (Hayes et al., 1998). Regardless as to whether 
elevated GnRH pulse frequency is a primary cause or a consequence of PCOS, it perpetuates the 
hyperandrogenemia that is characteristic of the disease.  
 
Elevated LH levels in women with PCOS may be secondary to loss of ovarian feedback during 
anovulatory cycles and/or to central dysfunction. To examine if elevated LH levels in PCOS are 
a consequence of lack of progesterone exposure, oral contraceptives (OC) were given to women 
with PCOS and to eumenorrheic women to stimulate luteal phase estrogen and progesterone 
levels. During OC treatment LH pulse frequency was elevated in women with PCOS compared 
to eumenorrheic women and this difference persisted after OC treatment was withdrawn, 
suggesting that central dysfunction in addition to lack of progesterone exposure drives the 
elevated LH:FSH ratios in PCOS (Daniels and Berga, 1997). Interestingly, women with PCOS 
treated with a 21-day course of estradiol and progesterone at levels typically seen during the 
luteal phase showed a delayed and less robust suppression of LH pulse frequency and amplitude 
compared to control females (Pastor et al., 1998). In a follow-up dose-response study, women 
with PCOS also required higher plasma progesterone levels to suppress LH frequency to the 
same degree as seen in control women with similar plasma progesterone levels (Pastor et al., 
1998). These data suggest that the hypothalamic response to ovarian feedback, not just altered 
hormonal milieu itself, contributes to abnormal gonadotropin secretion in PCOS. 
 
Effect of hyperandrogenemia on progesterone feedback 
Impaired sensitivity to progesterone feedback in PCOS may be an effect of elevated androgens. 
Adult women with elevated androgens due to congenital adrenal hyperplasia (CAH) have 
increased LH pulse amplitude compared to controls (Levin et al., 1991). Female primates 
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exposed to mildly elevated levels of testosterone during pubertal development showed increased 
LH pulse frequency and LH responsiveness to GnRH (McGee et al., 2012). These findings 
suggest that hyperandrogenemia can disrupt gonadotropin secretion. Adult female mice treated 
with testosterone showed blunted estradiol-induced progesterone receptor expression, suggesting 
impaired progesterone feedback as one potential mechanism through which elevated androgens 
could exacerbate the altered gonadotropin levels in PCOS (Foecking and Levine, 2005). 
Recordings of GnRH neuron firing in mouse brain slices have examined the effect of androgens 
on progesterone and estrogen feedback. In female OVX mice, treatment with combined 
progesterone and estradiol decreased GnRH neuron firing rates compared to treatment with 
estradiol alone (Pielecka et al., 2006). In contrast, treatment with combined androgen and 
estradiol increased GnRH neuron firing rate and the frequency of peaks in the firing rate 
compared to treatment with estradiol alone. This increase in GnRH firing rate persisted even 
with the addition of progesterone, suggesting that androgens interfere with progesterone negative 
feedback to GnRH neurons (Pielecka et al., 2006). Of interest in this regard, treatment with the 
androgen receptor antagonist flutamide for four weeks did not itself suppress either LH pulse 
frequency or LH responsiveness to GnRH in women with PCOS. However, flutamide treatment 
did restore sensitivity to progesterone negative feedback (Eagleson et al., 2000). Androgens may 
act through multiple mechanisms to alter GnRH neuron function, including through the upstream 
GnRH neuronal network.  
 
GABAergic network afferent to GnRH neurons 
Ovarian hormone feedback is likely conveyed to GnRH neurons through their afferent network. 
GnRH neurons themselves do not appear to express detectable levels of most ovarian steroid 
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receptors including estrogen receptor alpha (ERα), androgen receptor (AR) and progesterone 
receptor (PR) (Watson et al., 1992; Huang and Harlan, 1993; Skinner et al., 2001). GnRH 
neurons do express estrogen receptor beta (ERß) (Hrabovszky et al., 2007). Mice lacking ERα 
have loss of normal cyclicity, elevated LH and absent LH surges while mice lacking ERß have 
normal cycles, normal LH levels, and are fertile. These reproductive phenotypes indicate that 
ERα is primarily responsible for estradiol negative and positive feedback to GnRH neurons 
(Krege et al., 1998; Couse et al., 2003). Furthermore, estradiol induces expression of PR which is 
important for ovarian negative feedback (Romano et al., 1989; Chappell et al., 1997). Neuronal 
populations that express ERα or PR may communicate to GnRH neurons either directly or 
indirectly. Neurons that are sensitive to ovarian steroid hormones have been shown to project to 
GnRH neurons (Simonian et al., 1999; Wintermantel et al., 2006). This afferent network 
communicates hormone feedback signals to GnRH neurons through fast-synaptic transmission 
and neuropeptides  (Herbison, 2014). 
 
Fast-synaptic transmission through GABA and, to a lesser degree, glutamate are important 
sources of input to GnRH neurons (Jansen et al., 2003; Pielecka-Fortuna and Moenter, 2010). 
GnRH neurons have close appositions with GABAergic fibers (Leranth et al., 1985; Cottrell et 
al., 2006; Sergeeva and Jansen, 2009) and express both GABAA and GABAB receptors (Sim et 
al., 2000; Temple and Wray, 2005; Zhang et al., 2009). GABAergic neurons that express ERα, 
PR and AR are located in areas of the hypothalamus that are thought to project to GnRH neurons 
(Flugge et al., 1986; Leranth et al., 1992; Thind and Goldsmith, 1997; Scott et al., 2000). Of 
note, many neurons in the anteroventral periventricular area (AVPV) and the arcuate nucleus 
have been shown to express GABA (Horvath et al., 1997; Ovesjo et al., 2001; Hentges et al., 
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2004; Ottem et al., 2004). AVPV neurons also express ERα and GABA expression in AVPV 
neurons is increased at the time of the surge indicating that GABAergic neurons in the AVPV 
respond to estradiol feedback (Simerly et al., 1990; Ottem et al., 2004). Neurons in the AVPV, 
including those which express ERα, project to GnRH neurons (Gu and Simerly, 1997; Simonian 
et al., 1999). GABAergic neurons have thus emerged as one pathway for the ovarian hormone 
feedback loop to GnRH neurons.  
 
Functional studies have elucidated how ovarian hormone feedback is conveyed in part through 
GABAergic transmission to GnRH neurons. To examine the relative effects of different 
hormones, GABAergic PSCs were recorded in GnRH neurons in brain slices from OVX mice 
given hormone replacements. Progesterone and estradiol combination treatment decreased 
GABAergic PSC frequency and amplitude compared to estradiol treatment alone. This suggests 
that progesterone may alter pre and/or post-synaptic GABAergic signaling to GnRH neurons 
(Sullivan and Moenter, 2005). In support of the latter, the progesterone derivative 
allopregnanolone is an allosteric agonist of the GABAAR (Majewska et al., 1990). Application of 
allopregnanolone decreased PSC amplitude and altered kinetics of GABAergic PSCs in GnRH 
neurons. (Sullivan and Moenter, 2003). These data suggest that a potential mechanism for 
hormonal feedback regulation may be through modulation of the GnRH neuron response to 
GABA as allopregnanolone amplifies GABAAR-associated current in GnRH neurons from rats 
(Yin et al., 2008) and increases membrane potential depolarization in response to GABA 
application (Sim et al., 2001).  
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In contrast to progesterone, androgen treatment increased GABAergic PSC frequency and 
amplitude in GnRH neurons (Sullivan and Moenter, 2005). The androgen-mediated increase in 
GABAergic PSC frequency was activity-independent, suggesting that androgens act to increase 
synaptic connectivity of GABAergic afferents to GnRH neurons. Androgens may also modulate 
the postsynaptic current response of GnRH neurons to GABA. The androgen DHEAS 
allosterically modulates the GABAA receptor (Liu et al., 2002) and DHEAS treatment decreased 
GABAergic PSC amplitude in GnRH neurons (Sullivan and Moenter, 2003). Androgens may 
therefore interfere with progesterone negative feedback through opposing effects on GABAergic 
signaling. These effects may occur through direct action of ovarian hormones on GABAergic 
afferents of GnRH neurons and/or on steroid-sensitive populations further upstream.  
 
GnRH neuron response to GABAA receptor activation 
GABA is known as the major inhibitory neurotransmitter in the brain (Curtis and Johnston, 
1974) There are many exceptions to this generalized principle, including multiple cell types 
within the hypothalamus in which GABA has a depolarizing effect on membrane potential 
(Hewitt et al., 2009; DeFazio et al., 2014). GABAA receptors are ligand-gated ion channels that 
are primarily selective for chloride, although there is some permeability for other anions 
including bicarbonate (Kaila et al., 1989; Sigel and Steinmann, 2012). The direction and 
magnitude of the electrochemical driving force for chloride depends on the relative intracellular 
chloride concentration and the membrane potential. The potential at which there is no net driving 
force for chloride, and thus no net current, is known as the reversal or equilibrium potential. 
When GABAA receptors are activated, chloride ions will move down their electrochemical 
gradient, moving the cell membrane potential towards the GABAA reversal potential (Bevan et 
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al., 2000). The neuronal response to GABA therefore depends on the relative intracellular 
chloride concentration as determined by the relative expression and activity of chloride 
cotransporters. The chloride co-transporters Na-K-Cl (NKCC1) and K-Cl (KCC2) increase and 
decrease intracellular chloride, respectively (DeFazio et al., 2000). Many neuron types undergo a 
switch during development in their response to GABA through decreasing NKCC1 expression 
and increasing KCC2 expression (Rivera et al., 1999; Ben-Ari, 2002). GnRH neurons maintain 
elevated intracellular chloride concentrations in adulthood through their relatively increased 
expression of NKCC1 (DeFazio et al., 2002). The GABA equilibrium potential is depolarized 
from the average GnRH neuron resting potential, however inhibition of NKCC1 by the 
antagonist bumetanide results in relative hyperpolarization of the GABA equilibrium potential 
(DeFazio et al., 2002; Nakane and Oka, 2010). 
 
GnRH neurons from adult female mice, as well as other species including rats and fish, are 
depolarized by GABAA receptor activation and are excited to fire action potentials in response to 
GABA (DeFazio et al., 2002; Watanabe et al., 2009; Nakane and Oka, 2010). Furthermore, 
activation of GABAAR evokes an increase in intracellular calcium, a marker of cellular activity, 
in GnRH neurons (Constantin et al., 2010). Conversely, the GABAAR antagonist bicuculline has 
been shown to decrease GnRH neuron firing rate (Moenter and DeFazio, 2005). This experiment 
was performed in mouse brain slices that were first treated with ionotropic glutamate receptor 





Prenatal androgenization (PNA) 
Animal models have been used to gain insight into the mechanisms of neuroendocrine 
dysfunction in PCOS that cannot be studied in women. Various aspects of the PCOS phenotype 
have been recapitulated through prenatal exposure to elevated androgens (PNA) through 
maternal androgen treatment in several species including mice, rats, rhesus macaques and sheep 
(Birch et al., 2003; Sullivan and Moenter, 2004; Foecking et al., 2005; Abbott et al., 2008). The 
mechanism(s) of prenatal androgen effects on reproductive function is unclear as androgens may 
act on the mother, placenta and/or enter fetal circulation. Of interest in this regard, PNA rhesus 
monkey fetuses had elevated testosterone levels following maternal testosterone treatment 
despite high aromatase expression in the placenta, indicating that the fetus is directly exposed to 
androgen (Abbott et al., 2008). Testosterone levels in the umbilical veins of female newborns of 
mothers with PCOS were increased compared to levels in female newborns of control mothers 
(Barry et al., 2010). Furthermore, global heterozygous and homozygous androgen receptor knock 
out in female PNA mice were sufficient to protect against development of the PNA phenotype 
suggesting that these changes are dependent on androgen actions on the PNA fetus (Caldwell et 
al., 2015). 
 
Adult female PNA mice have impaired reproductive function as evidenced by irregular estrous 
cycles, reduced number of corpora lutea, and reduced litter size/fertility (Sullivan and Moenter, 
2004; Witham et al., 2012; Moore et al., 2013; Caldwell et al., 2014). These reproductive 
features are suggestive of ovulatory impairment similar to that seen in women with PCOS. PNA 
mice also show early onset of vaginal opening, an outward marker of female puberty, which may 
relate to the observation of reported early menarche in women with PCOS (Carroll et al., 2012; 
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Witham et al., 2012; Dulka and Moenter, 2016). Adult PNA mice also exhibit the hormonal 
changes commonly seen in women with PCOS including elevated testosterone and LH levels as 
well as relative glucose intolerance (Sullivan and Moenter, 2004; Moore et al., 2013).  
 
PNA animals have been used to examine the potential role of impaired ovarian hormone 
feedback in PCOS. Female PNA mice have a diminished LH increase following OVX compared 
to controls (Moore et al., 2013). Furthermore, OVX PNA mice had less suppression of LH in 
response to estradiol treatment compared to control OVX mice indicating impaired negative 
feedback (Moore et al., 2013). In contrast to negative feedback, the effect of PNA on positive 
feedback is less clear. OVX PNA mice and sheep appear to have typical estradiol-induced LH 
surges, suggesting that PNA does not alter estradiol positive feedback (Wood et al., 1995; Moore 
et al., 2013). However, sheep treated with prenatal androgens for days 30-86 of gestation, rather 
than days 65-86 as was done previously, did not have an estradiol-induced LH surge (Wood et 
al., 1995; Herbosa et al., 1996). OVX PNA sheep had a dramatically reduced proportion of 
GnRH neurons that expressed cFos, a protein used as a marker for neuronal activity, in response 
to an estradiol-induced surge protocol compared to controls, indicating loss of estradiol positive 
feedback (Wood et al., 1996). PNA may also interfere with progesterone feedback sensitivity, 
which is impaired in women with PCOS (Pastor et al., 1998; Levine et al., 2005; Veiga-Lopez et 
al., 2008). Progesterone implants decreased LH pulse frequency in control OVX ewes that were 
treated with estradiol. In contrast, there was no effect of progesterone on LH pulse frequency or 
amplitude in PNA OVX ewes treated with estradiol. (Robinson et al., 1999). Furthermore, the 
estradiol-induced increase in progesterone receptor expression in the hypothalamus was blunted 
in female PNA compared to control rats (Foecking et al., 2005). As hormone feedback is 
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communicated to GnRH neurons through their afferent network, the mechanism(s) of impaired 
hormone feedback in PNA mice may involve this network.  
 
PNA may induce functional and/or organizational changes in the GnRH neuronal network. 
GnRH neuron firing rate is increased and quiescent periods are decreased in PNA mice 
compared to diestrus controls (Roland and Moenter, 2011). The increase in GnRH neuron firing 
rate in PNA mice may be due, at least in part, to PNA-induced alterations in the afferent 
networks responsible for ovarian feedback, including GABAergic neurons. In line with this 
potential mechanism, GABAergic transmission frequency and amplitude to GnRH neurons is 
increased in adult female PNA mice (Sullivan and Moenter, 2004). Endogenous GABA can 
excite GnRH neurons from adult PNA female mice (Moenter and DeFazio, 2005), thus increased 
GABAergic transmission to GnRH neurons may contribute to the increased GnRH neuron firing 
seen in adult PNA mice. This increase in GABAergic transmission frequency is activity-
independent, suggesting that it arises due to increased synaptic connectivity rather than 
presynaptic activation. PNA mice and sheep also show an increase in GnRH neuron spine 
density, providing further evidence that synaptic connectivity is altered by PNA (Kim et al., 
1999; Moore et al., 2013). In adult PNA mice, short and long-term flutamide treatment was 
sufficient to reverse increases in GABAergic transmission frequency and amplitude (Sullivan 
and Moenter, 2004) suggesting that changes in the GnRH neuronal network are maintained at 





Androgens during development 
PCOS may arise from organizational changes to neuroendocrine circuits during prenatal 
development as well as activational effects of androgens during pubertal and/or adulthood 
(Abbott et al., 2005). During perinatal development, androgens and estrogens aromatized from 
androgens act to masculinize the formation and organization of neuronal networks (MacLusky 
and Naftolin, 1981). In adult mice, androgens have been shown to increase synaptic spines and 
transmission and may have a similar effect during development (Brawer et al., 1983; Garcia-
Segura et al., 1994; Hajszan et al., 2007; Hajszan et al., 2008). In mice, females express AR in 
the hypothalamus during late prenatal and early postnatal development (Mogi et al., 2015). 
Female adolescent and adult mice treated with androgens at levels that replicate anabolic steroid 
overuse showed decreased GABAergic transmission to GnRH neurons (Penatti et al., 2005; 
Penatti et al., 2011). These findings suggest that programming effects of androgens may underlie 
changes in the GnRH neuronal network seen in adult PNA mice. GABAergic synaptic 
organization is altered in adult PNA mice and GABAergic transmission to GnRH neurons is 
sensitive to androgens making this network a possible substrate for the effects of androgens on 
pre- and peripubertal neuroendocrine function (Sullivan and Moenter, 2003; Sullivan and 
Moenter, 2004; Moore et al., 2013).  
 
Developmental origin of PCOS  
The importance of the internal and external environment during development for shaping adult 
function has long been recognized and represents an important framework for understanding 
health and disease. Prepubertal girls with hyperandrogenemia are at increased risk of developing 
PCOS as adults (Knudsen et al., 2010). Obese girls are a useful group in which to study the 
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effects of prepubertal hyperandrogenemia because they have elevated testosterone levels 
compared to normal weight girls starting as early as Tanner stage 1 and continuing through 
puberty (Burt Solorzano et al., 2010). Hyperandrogenemia appears to be predominantly adrenal 
in these girls in contrast to adult women with PCOS in whom excess androgens come 
predominantly from the ovaries (Rosenfield et al., 2000). Of interest in this regard, girls with 
premature adrenarche are more likely to develop PCOS (Ibanez et al., 1998; Kousta, 2006). 
 
In addition to hyperandrogenemia, other features of adult women with PCOS, including elevated 
LH pulse frequency, can emerge during the pubertal transition (Tanner stages 3-4) (Blank et al., 
2006; Shayya and Chang, 2010; Collins et al., 2014). During the pubertal transition, girls 
typically progress from having increased nocturnal LH pulse frequency and amplitude (Wennink 
et al., 1990) to having greater daytime than nighttime LH levels. Premenarchal girls with 
hyperandrogenemia (HA) develop the mature pattern of LH pulses at younger ages than girls 
without HA (Apter et al., 1994). When compared to non-obese girls at the same Tanner stage, 
obese early pubertal girls did not show an overnight increased in LH amplitude but instead had 
elevated LH frequency at all times of day (McCartney et al., 2009). Interestingly, further studies 
showed that obese postmenarchal girls had elevated LH pulse frequency but that blunted day-
night changes in LH pulse frequency was seen only in those with hyperandrogenemia (Collins et 
al., 2014). Furthermore, the high LH pulse frequency in hyperandrogenemic girls was resistant to 
suppression by progesterone, similarly to women with PCOS (Chhabra et al., 2005; Collins JS, 
2013). However, it is not known if excess androgens during adolescence may be interfering with 
progesterone feedback in a similar manner as in adult women with PCOS. These studies suggest 
that hyperandrogenemia during peripubertal development leads to altered neuroendocrine 
 17 
function. However, it is not known when or how neuroendocrine changes may arise relative to 
pubertal development. If any changes exist, they may represent an important pathological step 
towards impaired negative feedback, overactive GnRH/LH pulse frequency and downstream 
ovarian androgen production characteristic of women with PCOS. Hyperandrogenemia may thus 
be both a cause and a consequence in a vicious cycle of neuroendocrine dysfunction in 
prepubertal girls and adult women with PCOS.  
 
The following chapter will examine the hypotheses that direct GABAergic transmission to 
GnRH neurons develops prepubertally in both sexes and that PNA alters the synaptic 
organization of this network prior to adult manifestations of reproductive dysfunction in females. 
We will further begin to characterize the response of GnRH neurons to GABA during 
prepubertal development and functional changes induced by PNA. Finally, we will discuss the 
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Chapter 2 Prepubertal development of GABAergic transmission to gonadotropin releasing 
hormone (GnRH) neurons and postsynaptic response are altered by prenatal 
androgenization  
 
Significance Statement  
The central neuronal network that regulates reproduction is overactive in polycystic ovary 
syndrome [PCOS), a leading cause of infertility. Recent evidence of neuroendocrine dysfunction 
in mid-pubertal girls suggests the pathophysiological mechanisms underlying PCOS may arise 
before pubertal maturation. Prenatal exposure to androgens (PNA) in mice mimics several 
neuroendocrine features of PCOS. GABAergic transmission to GnRH neurons is important for 
reproduction and is increased in adult PNA mice. Neither the typical development of this 
network nor when changes with PNA and sex arise relative to puberty are understood. These 
studies provide evidence that PNA alters prepubertal development of the GABAergic network 
afferent to GnRH neurons, including both the presynaptic organization and postsynaptic 
response. These changes may contribute to reproductive dysfunction in adults.  
 
Abstract  
GnRH neurons regulate reproduction through pulsatile GnRH release. Women with polycystic 
ovary syndrome have persistently elevated LH release frequency reflecting GnRH release; this 
exacerbates hyperandrogenemia and disrupted reproductive cycles characteristic of this disorder. 
Clinical evidence suggests neuroendocrine features of PCOS may manifest peripubertally. Adult 
mice prenatally exposed to androgens (PNA) mimic several reproductive features of PCOS. 
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GnRH neurons from these mice have increased firing activity and receive increased excitatory 
GABAergic transmission. When these changes emerge during development is unknown. To 
study typical postnatal development of GABAergic transmission and effects of PNA treatment 
and sex, whole-cell voltage-clamp recordings were made of GABAergic postsynaptic currents 
(PSCs) in GnRH neurons in brain slices from prepubertal through adult control and PNA female 
and male mice. GABAergic transmission was present by one-week of age in females and males 
and increased in frequency, reaching adult levels at three and four weeks, respectively. 
GABAergic PSC frequency was elevated in three-week-old PNA vs control females. PSC 
frequency in both controls and PNA mice was activity-independent, suggesting PNA induces 
changes in synapse organization. PNA also alters functional response of GnRH neurons to 
GABA. GABA induced firing in fewer neurons from three-week-old PNA than control females; 
membrane potential depolarization induced by GABA was also reduced in cells from PNA mice 
at this age. PNA thus induces changes during development in the presynaptic organization of the 
GABAergic network afferent to GnRH neurons as well as the postsynaptic GnRH neuron 
response, both of which may contribute to adult reproductive dysfunction. 
 
Introduction 
GnRH neurons form the final common pathway for central regulation of reproduction. GnRH is 
released in pulses (Clarke and Cummins, 1982; Moenter et al., 1992). During the typical female 
reproductive cycle, shifts from low to high frequency GnRH release help drive differential 
synthesis and secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) 
from the pituitary (Wildt et al., 1981; Haisenleder et al., 1991). FSH and LH regulate ovarian 
follicle maturation and steroidogenesis (Baird et al., 1976; Zeleznik and Fairchild-Benyo, 1994). 
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Steroid feedback in turn modulates GnRH/LH release (Leipheimer et al., 1984; Nippoldt et al., 
1989; Moenter et al., 1990; Tilbrook et al., 1991; McCartney et al., 2002). GnRH neurons do not 
express detectable levels of most steroid hormone receptors (Watson et al., 1992; Huang and 
Harlan, 1993; Skinner et al., 2001); therefore these signals are likely conveyed via steroid-
sensitive presynaptic inputs (Wintermantel et al., 2006; Cheong et al., 2015).  
 
The frequency of LH secretion (a bioassay for GnRH release) and steroid feedback regulation of 
LH release are altered in women with polycystic ovarian syndrome. PCOS is a leading cause of 
infertility, conservatively affecting 8% of reproductive-aged women (Goodarzi et al., 2011). 
Women with PCOS have persistently elevated GnRH/LH release frequency rather than cyclical 
shifts in pulse frequency (Burt Solorzano et al., 2012; McCartney and Marshall, 2016) and are 
less sensitive to progesterone negative feedback (Pastor et al., 1998). Increased GnRH release 
frequency contributes to the pathology of PCOS by altering LH and FSH levels, thus 
exacerbating elevated ovarian androgen production and irregular menstrual cycles characteristic 
of this disorder. Manifestations of nascent PCOS are increasingly being detected at younger 
ages; for example, evidence of elevated LH pulse frequency and hyperandrogenemia may be see 
in mid-pubertal girls (Tanner stages 3-4) (Blank et al., 2006; Shayya and Chang, 2010; Collins et 
al., 2014). These clinical findings suggest that antecedents of PCOS may arise during or even 
before pubertal development.  
 
Exposure to androgens during prenatal development produces neuroendocrine features similar to 
those of PCOS in adult animals, including rodents, sheep and rhesus macaques (Birch et al., 
2003; Sullivan and Moenter, 2004; Abbott et al., 2005; Foecking et al., 2005). Adult female 
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prenatally androgenized (PNA) mice have elevated LH pulse frequency, increased testosterone 
levels and disrupted estrous cycles (Sullivan and Moenter, 2004; Witham et al., 2012; Moore et 
al., 2015). GnRH neurons in brain slices from these mice have a higher firing rate (Roland and 
Moenter, 2011) and receive higher frequency GABAergic transmission (Sullivan and Moenter, 
2004; Roland and Moenter, 2011). GnRH neurons from control mice maintain high intracellular 
chloride even in adulthood and thus exhibit an excitatory response to GABA action via GABAA 
receptors (GABAARs) (DeFazio et al., 2002; Herbison and Moenter, 2011). Additionally, 
GABAergic fiber appositions to GnRH are increased in adult PNA mice (Moore et al., 2015). 
GABAergic afferents are important mediators of steroid feedback regulation of GnRH neuron 
function (Petersen et al., 2003; Sullivan and Moenter, 2005; Christian and Moenter, 2007; 
Pielecka-Fortuna and Moenter, 2010). Increases in GABAergic transmission could thus 
contribute to the increased GnRH neuron activity in the adult PNA mouse. 
 
Despite the importance of GABAergic afferents in the regulation of GnRH neurons, little is 
known about either the typical rates of GABAergic transmission across the pubertal transition or 
when differences attributable to sex or PNA exposure emerge. The prepubertal period and 
pubertal transition may be critical periods during which alterations in synaptic organization 
and/or function may have broad implications for adult reproductive physiology. We examined 
GABAergic synaptic transmission to GnRH neurons and GnRH neuron response to GABA in 
brain slices from prepubertal through adult female and male mice to understand the typical 




Materials and Methods 
All reagents were purchased from Sigma-Aldrich unless noted. 
Animals: GnRH-GFP B6 mice (Suter et al., 2000) were bred in our colony. All mice were 
provided with water and Harlan 2916 chow ad libitum and were held on a 14L:10D light cycle 
with lights on at 0400 Eastern Standard Time. To generate PNA mice, a GnRH-GFP and a CD1 
female were paired for 1-3 weeks and then a stud male introduced. Males were removed after 
pregnancy was established. PNA mice were generated by injecting pregnant GnRH-GFP dams 
with DHT (225 µg sc in sesame oil vehicle) on days 16–18 of gestation (day 1, copulatory plug 
observed). Controls (con) included mice from vehicle-treated or uninjected GnRH-GFP dams 
because in previous studies (Roland and Moenter, 2011), no differences were observed between 
these groups and they were combined for analysis. The CD1 mouse provided maternal and 
nutritional support that our observations indicate increase survival of PNA pups. Litter sizes 
were adjusted to <15 pups by culling CD1 pups to normalize nutrition. Pups not used for 
recordings were weaned at three weeks of age. Female and male mice at postnatal ages 1, 2, 3, 4 
weeks ± 1 day and adults (42-120 days old) were used for recording experiments. Experiments 
on female mice that had attained puberty were done on diestrus. The Institutional Animal Care 
and Use Committee of the University of Michigan approved all procedures.   
 
Brain slice preparation: All solutions were bubbled with 95% O2/5% CO2 throughout the 
experiments and for at least 15 minutes before exposure to tissue. Brain slices were prepared 
through the preoptic area as previously described (DeFazio et al., 2002; Chu and Moenter, 2005; 
Glanowska and Moenter, 2015; Ruka et al., 2016). Briefly, brains were rapidly removed and 
placed in ice-cold sucrose saline containing (in mM): 250 sucrose, 3.5 KCL, 26 NaHCO3, 10 
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glucose, 1.25 Na2HPO4, 1.2 MgSO4, and 3.8 MgCl2. Coronal slices (300 µm) were made using a 
LeicaVT12000S vibratome (Leica Biosystems). Slices were incubated at room temperature for 
30 minutes in a 50-50 solution of sucrose saline and ACSF containing (in mM): 135 NaCl, 3.5 
KCL, 26 NaHCO3, 10 D-glucose, 1.25 Na2HPO4, 1.2 MgSO4, 2.5 CaCl2, 310 mOsm/L, pH 7.4. 
Slices were then transferred to 100% ACSF at room temperature for 0.5-5 h before recording. 
Slices were used within 6 hours of preparation.  
 
Electrophysiology recording and data acquisition: Slices were transferred to a recording 
chamber and perfused with oxygenated ACSF at a rate of 3 mL/min at 30±1ºC. ACSF contained 
20 µM CNQX and 20 µM APV (Tocris Bioscience) to block ionotropic glutamate receptors. 
When ionotropic receptors for both glutamate and GABA are blocked, no fast-synaptic 
transmission is detected in GnRH neurons, suggesting that these inputs account for the vast 
majority of fast synaptic transmission (Sullivan et al., 2003). Recording pipettes were pulled 
from borosilicate glass pipettes (World Precision Instruments, 1.65/1.1 mm OD/ID) using a P-97 
puller (Sutter Instruments). Pipettes were filled with a solution containing 140 mM KCl, 10 mM 
HEPES, 5 mM EGTA, 0.1 mM CaCl2, 4 mM MgATP and 0.4 mM NaGTP, pH 7.2, 310 
mOsm/L. Pipettes with resistances of 2-4 MW when filled with this pipette solution were used. 
All voltages reported were corrected for liquid junction potential during analysis. GnRH-GFP 
neurons were identified by brief illumination with 470 nm light using an Olympus BX51WI 
microscope. Recordings were made using one channel of an EPC-10 dual patch-clamp amplifier 
and Patchmaster acquisition software (Heka Elektronic) running on a Macintosh G4 computer. 
Membrane currents were filtered at 6.5 kHz and digitized at 10 kHz. Cell location was noted and 
mapped to an atlas to determine if cell location-based differences emerged (Paxinos and 
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Franklin, 2001). No differences in response attributable to rostral-caudal and medial-lateral 
distribution were evident. No more than three cells were recorded per animal. The variability 
between GnRH neurons recorded from a single mouse was similar to the variability of GnRH 
neurons among mice.  
 
GABAergic postsynaptic current (PSC) recordings: Whole-cell voltage-clamp recordings were 
made following formation of a high resistance seal (≥1.3 GΩ) between the pipette tip and cell 
membrane. Spontaneous GABAergic PSCs (sPSCs) were recorded at -55 mV. In some cells, 
activity-independent miniature PSCs (mPSCs) were recorded in the presence of 1µM TTX 
following measurement of sPSCs. To monitor cell health and recording quality, input resistance 
(>500 MW), series resistance (<20 MW uncompensated, <20% change during the analyzed 
recording period), holding current (-60 pA to +5 pA) and membrane capacitance (stable) were 
measured every 2 min from the average of 16 traces recorded in response to a 5 mV 
hyperpolarizing step; traces with synaptic activity were excluded from analyses.  
 
GABA application: Local pressure application of GABA was accomplished as described 
(DeFazio et al., 2014). Pipettes were filled with 100 µM GABA in a HEPES-buffered saline 
solution containing (in mM): 150 NaCl, 10 HEPES, 10 glucose, 3.5 KCl, 2.5 CaCl2, 1.3 MgCl2, 
pH 7.2 with NaOH. This pipette was placed ~15 µM from the soma, and a pulse of 5-10 psi was 
delivered using a PV820 picospritzer (World Precision Instruments, Inc.). To determine if 
GABA induces firing activity in GnRH neurons, on-cell voltage-clamp recordings were made 
and the response to GABA was evaluated during a 150 ms window after rapid GABA 
 36 
application. This was repeated three times per cell with ≤30 s between measurements. Pressure 
application of the HEPES-buffered solution without GABA did not induce firing (data not 
shown).  
 
To assess the membrane potential response to rapid GABA application, membrane potentials 
were measured in the on-cell configuration as described (Fricker et al., 1999; Verheugen et al., 
1999; DeFazio et al., 2014). Briefly, membrane potential is calculated by measuring potassium 
current in response to a voltage ramp from -100 to +200 mV over 50 msec. This method assumes 
that the intracellular concentration of potassium is similar to that in the pipette solution, resulting 
in a reversal potential for potassium (EK) across the patch near 0 mV. Under these conditions, the 
only driving force for potassium current is the potential difference across the patched cell 
membrane, thus the ramp potential at which the leak-corrected potassium current is 0 pA reveals 
the membrane potential of the cell. Repeating this procedure twice at 100 ms intervals allows 
baseline membrane potential to be estimated, a puff of GABA applied locally, and membrane 
potential in response to GABA estimated. This entire process was repeated 4-12 times per cell 
with ≥30 s between measurements. The average of the measurements is reported for each cell. 
 
Gramicidin perforated-patch recordings: Gramicidin perforated-patch recordings were 
performed as in (DeFazio et al., 2002) with minor modifications. Gramicidin stock solutions (50 
mg/mL in DMSO) were prepared weekly, protected from light and kept at 4oC. Working 
concentration (50-100 µg/mL) was made fresh for each cell in pipette solution and sonicated for 
10-20 seconds immediately before use. Patch pipettes (2−4.5 MΩ) were back filled with 1.5-2.5 
µl of gramicidin-free pipette solution followed by gramicidin solution. Two pipette solutions 
 37 
were used, one with high chloride and one with low chloride; values obtained with these two 
solutions will be similar if inadvertent patch rupture has not occurred. Low chloride pipette 
solution consisted of (in mM): 139 mM K gluconate, 1 mM KCl, 10 mM HEPES, 5 mM EGTA, 
0.1 mM CaCl2, 4 mM MgATP and 0.4 mM NaGTP, pH 7.2, 310 mOsm/L. For high chloride 
pipette solution, K gluconate was replaced with KCl. Membrane potential for recordings with 1 
mM or 140 mM chloride were corrected for liquid junction potentials of 16.5 mV and 4.9 mV, 
respectively.  
 
After obtaining a minimum of 1 GΩ resistance seal, 5 mV hyperpolarizing steps from a holding 
potential of -65 mV were made in voltage-clamp to monitor membrane perforation. Recordings 
were initiated when the series resistance fell below 50 MΩ. Voltage steps (-80 mV to +5 mV, 15 
mV interval, 500 ms) were paired with local GABA application as described above to determine 
the reversal potential; GABA was applied 300 ms into the 500 ms voltage step to allow the 
membrane current to stabilize before drug application. A 5 mV hyperpolarizing step was given 
before the start of each voltage step to determine series resistance; each step potential was 
independently corrected for voltage error resulting from series resistance in the analysis. Voltage 
steps and accompanying GABA application were delivered at 30 s intervals to ensure that 
applied GABA was cleared between measurements. Baseline current was measured just before 
GABA application, and GABA response was determined as the peak current following GABA 
application. The reversal potential was determined from the crossing of the current-voltage 
relationship of the baseline current and the GABA response using a custom-written software in 
IGOR Pro and was verified by eye for each recording. Only reversals that were stable (<5 mV 
variation) for at least two complete measurements were accepted. Rupture of perforated-patch 
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recordings to whole-cell mode was detected by an abrupt decrease in access resistance, increase 
in membrane capacitance, broadening on capacitive transient shape and rapid change in the 
measured reversal potential (hyperpolarized with 1 mM chloride pipette solution, depolarized 
with 140 mM chloride pipette solution). Any recordings in which any of these changes was 
detected were discarded. 
 
Analysis: PSC data were analyzed using custom software (Sullivan et al., 2003; DeFazio et al., 
2014) written in IgorPro (Wavemetrics). Every PSC was visually confirmed. Frequency is the 
total number of events detected divided by the duration of the recording. Amplitude, rise time, 
decay and full-width half maximum (FWHM) are reported as the mean ± SEM of all events in a 
recording. Rise time was quantified from baseline to half of the maximum amplitude of the PSC. 
Decay time was calculated as the time between 90% and 10% of the maximum current 
amplitude. 
 
Statistics: Data are reported at mean ± SEM. Data were examined for normal distribution using 
the Shapiro-Wilk test. Statistical analyses were performed (GraphPad Prism) with tests dictated 
by data distribution and experimental design; specific tests are indicated in the figure legends and 
tables. For age and sex comparisons, two-way ANOVA followed by Fisher’s least significant 
difference post hoc was used; this choice was justified by the large number of comparisons made 
(i.e., 45 different comparisons between either sex or treatment at five different ages). p<0.05 was 




GABAergic transmission to GnRH neurons occurs before puberty in females and males.  Whole-
cell voltage-clamp recordings of spontaneous GABAergic PSC frequency in GnRH neurons 
were made in brain slices from 1, 2, 3 and 4-week old and adult female and male control and 
PNA mice (number of cells per group shown in Table 1). There were no differences in passive 
properties except for capacitance which was increased with age but was not altered by sex or 
PNA treatment. These changes would not be expected to affect the data reported. (Table 2, 3). 
Representative recordings are shown in Figure 1, group comparisons in Figure 2 and Table 4. 
Low frequency GABAergic transmission was observed at one week of age in all cells studied. In 
cells from control females, GABAergic transmission frequency increased between two and three 
weeks of age (p<0.05, Figure 2A). In cells from control males, an increase was not observed 
until four weeks of age (p<0.05). PSC frequency was higher in males than females at four weeks 
of age (p<0.05). Androgenization of PNA mice was confirmed in surviving female littermates by 
younger age of vaginal opening (32.9±0.6 days old n=20 con vs 28.7±0.4 days old PNA n=21, 
p<0.05), disrupted estrous cycles (time spent in estrus, 23% con n=12 vs 8% PNA n=12 p<0.05) 
and greater anal-genital distance (5.5±0.2 mm con n=12 vs 6.6±0.3 PNA n=12 p<0.05). 
 
Table 1. Cells/group for sPSC recordings. 
age (wks) CON ♀ PNA ♀ CON ♂ PNA ♂ 
1   7 13   6   5 
2 13   8   7   5 
3 11 12 13   9 
4 11 15 11 10 
>6   9 13   6 10 
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1 1205±265 16.9±4.1 9.6±2.9 -33.9±8.4 
2 1063±541 14.2±2.7 12.5±2.8 -42.5±15.3 
3 1022±236 15.5±3.7 12.5±3.0 -36.8±16.2 
4 1193±336 16.7±4.7 12.2±3.9 -34.4±16.6 
>6 1263±354 16.5±4.8 13.3±2.9   -32.0±15.0 
♀ 
PNA  
1 1181±345 16.6±3.2 10.8±4.7 a -41.5±12.9 
2 1166±340 14.5±3.6  13.5±6.2  -35.9±15.0 
3 1147±436 14.9±4.5  12.1±4.4  -38.8±14.2 
4 1135±303 13.9±4.1  13.3±2.3 b -31.7±11.2 
>6 1203±308 16.0±5.1  14.6±2.1 b -35.9±18.2  
♂ 
CON 
1 1293±279   17.4±6.3 14.1±9.2 a  -35.7±12.1  
2 946±279  15.6±2.1 10.2±1.0 a  -44.7±13.3  
3 1127±282 16.2±3.3  12.5±3.3 a  -31.5±9.2  
4 989±279 14.6±2.3 12.2±2.7 a  -43.0±20.8  
>6 851±184  15.1±4.8 16.7±2.9 b  -48.0±26.4  
♂ 
PNA  
1 1180±312 16.0±3.5  8.4±2.7 a  -41.8±20.7  
2 939±242 16.1±4.9  15.0±8.8 b  -46.5±6.9  
3 921±330 13.4±4.8   13.3±6.5 b -45.9±12.9  
4 942±272 15.5±4.4  12.7±3.3  -41.0±13.0 
>6 1146±472 15.1±4.6  13.8±3.4 b -33.4±17.6  
Different lower case letters indicate differences with age within a group. Significant differences 
defined as p<0.05. Values without letters are not different from any other age, sex or treatment. 
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Table 3. Two-way ANOVA parameters for comparison of membrane properties among groups 
Groups Parameter  Sex Age Interaction 
Con ♀ vs 
Con ♂ 
Input resistance F(1, 84)=1.72 F(4, 84)=0.82 F(4, 84)=1.56 
Series resistance F(1, 84)= 0.03 F (4, 84)=0.42 F (4, 84)=0.71 
Capacitance F(1, 84)=0.26 F(4, 84)=4.66** F(4, 84)=1.92 
Holding current F(1, 84)=0.97 F(4, 84)=0.14 F(4, 84)=0.93 
PNA ♀ vs 
Con ♂ 
Input resistance F(1, 94)=3.36 F(4, 94)=1.02 F(4, 94)=0.92 
Series resistance F(1, 94)=1.52 F(4, 94)=0.83 F(4, 94)=0.81 
Capacitance F(1, 94)=0.07 F(4, 94)=2.53* F(4, 94)=0.29 
Holding current F(1, 94)=0.03 F(4, 94)=1.05 F(4, 94)=0.99 
Groups Parameter Treatment Age Interaction 
Con ♀ vs 
PNA ♀ 
Input resistance F(1, 102)=0.07 F(4, 102)=0.49 F(4, 102)=0.73 
Series resistance F(1, 102)=1.76 F(4, 102)=0.44 F(4, 102)=0.70 
Capacitance F(1, 102)=0.03 F(4, 102)=2.38 F(4, 102)=0.51 
Holding current F(1, 102)=1.13 F(4, 102)=0.86 F(4, 102)=0.32 
Con ♂ vs 
PNA ♂ 
Input resistance F(1, 73)=0.11 F(4, 73)=2.02 F(4, 73)=0.91 
Series resistance F(1, 73)=1.47 F(4, 73)=0.41 F(4, 73)=1.81 
Capacitance F(1, 73)=0.01 F(4, 73)=2.71* F(4, 73)=1.96 







Figure 1. Representative recordings of GABAergic PSCs in GnRH neurons in female (F, left) 
and male (M, right) control (top) and PNA (bottom) mice at ages A, one week; B three weeks; C, 
four weeks; D, adults >6 weeks. 
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Figure 2. Spontaneous GABAergic transmission frequency to GnRH neurons changes 
throughout the prepubertal period in both sexes and is altered by PNA. A-D, Individual values 
and mean ± SEM of GABAergic PSC frequency at 1, 2, 3, 4 weeks and adults >6 weeks. A, 
control females (open circles) and males (black circles), two-way ANOVA/Fisher’s LSD B, 
control and PNA (magenta circles) females, two-way ANOVA/Fisher’s LSD. C, control and 
PNA (blue circles) males, two-way ANOVA/Fisher’s LSD. D, PNA females and control males, 
two-way ANOVA/Fisher’s LSD. Different letters of the same case indicate differences with age 






Table 4. Two-way ANOVA parameters for comparison of sPSC frequency, amplitude and 
membrane potential change among groups 
Parameter (Figure 
displaying data) Sex/Treatment Age Interaction 
sPSC frequency (2A) F(1, 84)=1.72 F(4, 84)=5.64*** F(4, 84)=2.20* 
sPSC amplitude (3A) F(1, 84)=0.17 F(4, 84)=1.76 F(4, 84)=1.30 
sPSC frequency (2B) F(1, 102)=9.45** F(4, 102)=8.44**** F(4, 102)=1.57 
sPSC amplitude (3B) F(1, 102)=0.01 F(4, 102)=0.5 F(4, 102)=0.7 
sPSC frequency (2C) F(1, 73)=3.63* F(4, 73)=7.77**** F(4, 73)=1.24 
sPSC amplitude (3C) F(1, 73)=0.07 F(4, 73)=3.03* F(4, 73)=0.88 
sPSC frequency (2D) F(1, 94)=6.37* F(4, 94)=7.14**** F(4, 94)=3.73** 
sPSC amplitude (3D) F(1, 94)=0.20 F(4, 94)=0.82 F(4, 94)=1.80 
mPSC frequency (5A) F(1, 43)=3.63* F(3, 43)=2.78* F(3,43)=1.47 
mPSC amplitude (5B) F(1, 43)=0.37 F(3,43)=0.61 F(3,43)=1.62 
∆ membrane potential (5F) F(1, 56)=2.3 F(3, 56)=2.4 F(3, 56)=2.1 
*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001 
 
PNA alters prepubertal development of GABAergic transmission to GnRH neurons in females 
and males. In cells from PNA females, GABAergic transmission frequency increased between 
two and three weeks of age as in controls, but the increase was more robust in PNA females 
(Figure 2B). As a result, PSC frequency was elevated in cells from PNA compared to control 
females at three weeks of age (p<0.05); this increase was maintained in adults (p<0.05), 
confirming previous observations (Sullivan and Moenter, 2004). In males, GABAergic 
transmission frequency was increased at four weeks of age in cells from PNA compared to 
control males (p<0.05), but not in adulthood (p=0.085, Figure 2C). To address the question of 
whether or not GABAergic transmission in PNA females reflects masculinization of the network, 
we compared PNA females to control males (Figure 2D). Cells from PNA females had higher 
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GABAergic PSC frequency than cells from control males at three weeks of age (p<0.05), and in 
adults (p<0.05). GABAergic transmission in cells from PNA females thus showed a different 
pattern of prepubertal development from control males. There was no effect of age, sex or 
treatment on GABAergic PSC amplitude (Figure 3, Table 4). There was no overall trend with 
age, sex or treatment in sPSC kinetics (Table 5 and 6). FWHM was smaller at four weeks in 
control females and thus elevated in controls at two weeks of age and in adults. 
 
Figure 3 Amplitude of spontaneous GABAergic PSCs is not altered by PNA or sex. A-D, 
Individual values and mean ± SEM (crosses) of GABAergic PSC amplitude at 1, 2, 3, 4 weeks 
and adults >6 weeks. No differences were seen when analyzed using a two-way 
ANOVA/Fisher’s LSD. A, control females (open circles) and males (black circles) B, control 
and PNA (magenta circles) females. C, control and PNA (blue circles) males. D, PNA females 
and control males.  
 46 
Table 5. .Mean±SEM kinetic parameters of GABA sPSCs in GnRH neurons. 
Group age (wks) rise time (ms) decay (ms) FWHM (ms) 
♀ CON 
1 0.37±0.06 17.2±2.2 5.99±0.75  
2 0.38±0.06 18.8±1.0 6.72±0.53 a 
3 0.52±0.08 17.0±1.4 5.42±0.32 
4 0.49±0.09 19.2±1.5 4.17±0.65 b 
>6 0.43±0.11 19.4±1.5 6.41±0.64 a 
♀ PNA  
1 0.52±0.17 18.8±3.5 5.94±0.57  
2 0.50±0.10  23.1±2.4 6.69±0.57 
3 0.32±0.07  18.4±1.7 4.99±0.58 
4 0.49±0.05  17.4±1.0 5.92±0.38 
>6 0.42±0.07 20.9±1.0 6.02±0.82 
♂ CON 
1 0.62±0.14 22.6±3.2 7.57±0.13  
2 0.40±0.08 20.4±3.0 6.69±0.57  
3 0.31±0.10  18.2±2.8 7.73±1.06  
4 0.33±0.09 20.6±2.0 5.92±0.38  
>6 0.22±0.09 20.7±1.5 6.02±0.82  
♂ PNA  
1 0.35±0.08 23.3±2.8 a 6.39±0.61  
2 0.29±0.09  25.2±0.9 a 8.30±0.59 
3 0.57±0.05 14.3±2.2 b 5.38±0.52 
4 0.48±0.08 20.2±1.1 6.76±0.51 
>6 0.36±0.05 21.9±2.2 a 5.99±0.46 
Different lower case letters indicate differences with age within a group. Significant differences 






Table 6. Two-way ANOVA parameters for comparison of GABA sPSC kinetics among groups  
Groups Parameter  Sex Age Interaction 
Con ♀ vs 
Con ♂ 
Rise time F(1, 84)=3.24 F(4, 84)=0.30 F(4, 84)=1.04 
decay F(1, 84)= 2.86 F (4, 84)=0.60 F (4, 84)=0.33 
FWHM F(1, 84)=2.10 F(4, 84)=0.22 F(4, 84)=0.23 
PNA ♀ vs 
Con ♂ 
Rise time F(1, 94)=4.48* F(4, 94)=1.40 F(4, 94)=0.40 
decay F(1, 94)=0.30 F(4, 94)=0.96 F(4, 94)=0.79 
FWHM F(1, 94)=0.20 F(4, 94)=0.16 F(4, 94)=0.17 
Groups Parameter Treatment Age Interaction 
Con ♀ vs 
PNA ♀ 
Rise time F (1, 67) = 0.08 F (4, 67) = 0.30 F (4, 67) = 1.29 
decay F(1, 102)=1.84 F(4, 102)=1.68 F(4, 102)=1.14 
FWHM F(1, 102)=0.05 F(4, 102)=3.12* F(4, 102)=0.65 
Con ♂ vs 
PNA ♂ 
Rise time F(1, 73)=2.00 F(4, 73)=1.13 F(4, 73)=1.86 
decay F(1, 73)=0.12 F(4, 73)=2.81* F(4, 73)=0.90 
FWHM F(1, 73)=0.30 F(4, 73)=0.40 F(4, 73)=0.40 
*p<0.05 
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The frequency of GABAergic transmission to GnRH neurons is activity-independent. Increased 
frequency of neurotransmission with postnatal development or PNA treatment could result from 
increased presynaptic activity and/or increased synaptic connectivity to GnRH neurons. To 
distinguish between these mechanisms, the fast voltage-gated sodium channel blocker 
tetrodotoxin (TTX) was added during recordings to isolate activity-independent 
neurotransmission, which is proportional to the number of functional synaptic connections 
(Auger and Marty, 2000; Kaeser and Regehr, 2014). As with sPSCs, mPSC frequency was 
increased in adult PNA females compared to controls; in three-week old females, mPSC 
frequency did not meet criteria for statistical significance (p=0.104, Figure 4A, Table 4). Neither 
amplitude nor kinetics of mPSCs differed with age or PNA treatment (Figure 4B, Table 4, 7 and 
8). Similarly, comparison of sPSC and mPSC frequency and amplitude in the same cell revealed 
no difference with age or PNA treatment (Figure 4C, D, Table 9).  
 
Table 7 Mean±SEM kinetic parameters of GABA mPSCs in GnRH neurons.  
Group age (wks) rise time (ms) decay (ms) FWHM (ms) 
♀ CON 
2 0.41±0.22 22.40±5.06 6.60±0.96  
3 0.31±0.20 20.61±4.04 5.10±0.62 
4 0.49±0.40 22.05±2.67 5.28±0.33  
>6 0.29±0.17 20.63±3.66 6.18±0.99 
♀ PNA 
2 0.60±0.33 17.29±7.28 5.74±0.22  
3 0.50±0.40 18.84±6.54 6.61±0.61  
4 0.38±0.25 20.12±5.59 6.49±0.38  
>6 0.37±0.25 23.17±4.40 7.27±0.55 




Table 8. Two-way ANOVA parameters for comparison of GABA mPSC kinetics in control vs 
PNA females.  
Groups Parameter Treatment Age Interaction 
Con ♀ vs 
PNA ♀ 
Rise time F(1, 43)=0.341 F(4, 43)=0.923 F(4, 43)=0.206 
decay F(1, 43)=0.808 F(4, 43)=2.24 F(4, 43)=1.53 
FWHM F(1, 43)=0.161 F(4, 43)=2.12 F(4, 43)=0.0929 
No differences were observed among groups. 
 
Table 9. Two-way repeat-measures ANOVA parameters for comparison of sPSCs and mPSCs  
Factor 
age 
(wks) Treatment TTX Interaction CON n PNA n 
frequency 
2 F(1,9)=0.8 F(1,9)=2.3 F(1,9)=1.4 5 6 
3 F(1,10)=1.0 F(1,10)=0.3 F(1,10)=0.08 7 6 
4 F(1,10)=0.5 F(1,10)=2.5 F(1,10)=1.8 6 6 
>6 F(1,9)=4.5 F(1,9)=0.07 F(1,9)=0.15 6 5 
amplitude 
2 F(1,9)=0.6 F(1,9)=2.9 F(1,9)=1.5 5 6 
3 F(1,10)=0.7 F(1,10)=3.2 F(1,10)=0.01 7 6 
4 F(1,10)=0.8 F(1,10)=0.1 F(1,10)=2.8 6 6 
>6 F(1,9)=0.79 F(1,9)=0.01 F(1,9)=0.001 6 5 
No differences were observed among groups. 
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Figure 4. Activity-independent GABAergic transmission to GnRH neurons does not change 
throughout the prepubertal period or with PNA treatment in females. Individual values and mean 
± SEM (crosses) of A. mPSC frequency and B. mPSC amplitude at 1, 2, 3, 4 weeks and adults 
>6 weeks. Data for control females (open circles) and PNA females (magenta circles) were 
compared with two-way ANOVA/Fisher’s LSD. Different lower-case letters indicate differences 
with age within a group; * indicates p<0.05 between groups at each age. GABAergic PSC 
frequency (C) and amplitude (D) in cells under control conditions (no ttx, open circles), and in 
the presence of 1 µM TTX (ttx, closed circles). Data for each age were compared with two-way 
repeated-measures ANOVA/Fisher’s LSD. Lines connect measurements made with and without 
TTX in the same cell.  
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PNA alters the functional response of GnRH neurons from prepubertal female mice to acutely 
applied GABA. Because our main interest was in examining potential neurobiological 
mechanisms underlying PCOS, further studies were confined to females. Increased GABAergic 
transmission frequency during development could induce compensatory changes within GnRH 
neurons to alter response to GABA; alternatively, altered response of GnRH neurons to GABA 
could lead to changes in their presynaptic network. We hypothesized that PNA affects functional 
response of GnRH neurons to GABAA receptor activation. To examine this, we first measured 
firing during an acute local application of exogenous GABA. This approach allows for rapid 
saturation of GABAA receptors with minimal receptor desensitization in order to study the 
membrane response to GABA, but does produce a longer exposure to transmitter than synaptic 
release provides (Figure 5A). The on-cell configuration was used to avoid disrupting the 
intracellular chloride concentration, upon which the response to activation of the GABAA 
receptor depends (Succol et al., 2012). As reported (DeFazio et al., 2002; Sullivan et al., 2003), 
GABA induces firing in GnRH neurons from adult control females (Figure 5B, F). In adults, 
PNA did not affect GnRH neuron firing response to GABA (Figure 5C, F). During development, 
GABA evoked firing in the majority (96%, 27 of 28) of GnRH neurons from control prepubertal 
mice (Figure 5D, F). In contrast, only 59% of GnRH neurons (13 of 22) from PNA mice fired in 
response to GABA during development (Figure 5E, F, p<0.05 vs con). Lack of response was 
concentrated at three weeks of age, with only 33% (3 of 9) of GnRH neurons firing in response 
to GABA (p<0.05 vs con), vs 83% (5 of 6) of cells from two-week old and 71% (5 of 7) of cells 
from four-week old PNA females (Figure 5F). The percentage of firing cells was not different 
between PNA and control at two (p=0.462) or four (p>0.99) weeks of age. There were no 
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changes in input resistance or capacitance with PNA that would contribute to the observed 
differences (Table 2 and 3). 
 
Figure 5. Response of GnRH neurons from PNA mice to acute GABA application is blunted at 
three weeks of age. A, Whole-cell voltage-clamp recording of current response to GABA in 
GnRH neuron from an adult control female. B-E, Representative on-cell recordings of firing 
response (vertical action currents) to GABA in cells from B, adult control C, adult PNA D, 
three-week-old control and E, three-week-old PNA female mice. A-E are on the same time scale. 
F, percentage of GnRH neurons that fire in response to GABA. Number of cells studied is shown 
within each bar (Fisher’s exact test for each age group,*, p<0.05). G, individual values (circles) 
and mean±SEM (crosses) of the magnitude of GABA-induced membrane depolarization (two-




GABA-induced membrane potential depolarization of GnRH neurons is blunted in cells from 
three-week old PNA mice. The altered firing response of GnRH neurons to GABA in prepubertal 
PNA mice is likely attributable to changes in the membrane potential response. GABA-induced 
current may depolarize, hyperpolarize or have no effect on membrane potential. To determine if 
PNA changes membrane response to GABA, we measured the membrane potential before and 
during response to acutely applied GABA. There was no difference in the baseline membrane 
potential of GnRH neurons from female mice at any age or with prenatal treatment (Table 10). 
GABA induced membrane depolarization in all GnRH neurons studied at all ages (Figure 5G). In 
GnRH neurons from PNA females, however, the magnitude of depolarization was blunted at 
three weeks of age compared to controls (p<0.05). 
Table 10. Baseline membrane potential of GnRH neurons.  
age (wks) CON ♀ PNA ♀ 
2 -63.4±1.9 mV n=12 -65.4±2.9 mV n=8 
3 -66.3±1.1 mV n=7 -61.9±1.6 mV n=11 
4 -63.3±0.9 mV n=7 -63.9±1.9 mV n=7 
>6 -64.7±1.8 mV n=5 -65.0±1.4 mV n=5 
No differences were observed among groups; treatment F(1, 84)=0.01, age F(4, 84)=0.07, 
interaction F(3, 58)=1.25 
 
Reversal potential for GABAA-receptor-mediated current (EGABA) is not altered by PNA in three-
week-old females. Gramicidin perforated-patch recordings were used to measure the reversal 
potential for the GABAA receptor-mediated current (EGABA, Figure 6). EGABA was not different 
between control and PNA mice at three weeks of age. No difference in EGABA was observed 
between measures made using 1 mM vs 140 mM chloride pipette solutions, indicating the 
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measured reversal potentials were dependent on intrinsic chloride concentration and were not 
contaminated by the recording. 
 
Figure 6. Reversal potential for GABAAR-mediated current (EGABA) is not altered by PNA in 
GnRH neurons from three-week-old females. A, Top, voltage step protocol from -65 mV to -20 
mV, bottom representative gramicidin-perforated patch recording showing current response to 
voltage steps. * and # show where measurements were made of baseline and GABAAR-mediated 
current, respectively. Capacitive transients at the start and end of the variable step protocol were 
truncated for clarity. B, measurements of EGABA in control and PNA females. Open and closed 
circles show recordings using 1 mM and 140 mM chloride pipette solutions, respectively. Data 
analyzed using two-tailed, unpaired Student’s t-test, p=0.7048. 
 
Discussion 
Neuroendocrine changes are present in most women with PCOS and similar changes have been 
shown to emerge during puberty in hyperandrogenemic girls (Yoo et al., 2006; Collins et al., 
2014). Adult PNA mice recapitulate several features of PCOS and allow neurobiological 
mechanisms to be examined. GABAergic transmission to GnRH neurons is elevated in these 
mice in adulthood (Sullivan and Moenter, 2004). GABA levels in CSF from women with PCOS 
are also higher than controls (Kawwass et al., 2017). We examined effects of PNA treatment and 
sex on development of GABAergic transmission to GnRH neurons and their postsynaptic 
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response to GABA. GABAergic transmission frequency increases during prepubertal 
development in both sexes. In females, PNA increases transmission frequency during prepubertal 
development but blunts the excitatory postsynaptic response to GABA in these cells, despite not 
altering EGABA.  
 
In all groups, low-frequency GABAergic transmission to GnRH neurons was observed at one-
week of age. Transmission frequency increased to adult levels before outward signs of puberty 
were observed. The present findings support and extend work showing high frequency GnRH 
release in brain slices from postnatal males (Glanowska et al., 2014), and a preliminary report of 
high frequency GnRH neuron firing activity in both sexes (Dulka and Moenter, 2016). Together 
these observations make a strong case that the GnRH neuronal network is active well before 
maturation of the downstream reproductive system. This suggests GnRH neuron activity during 
postnatal/pubertal development may have a role beyond reproductive output, such as sculpting 
formation and stabilization of nascent synapses (Katz and Shatz, 1996; Andreae and Burrone, 
2014). The increase in GABAergic transmission to GnRH neurons during prepubertal 
development likely reflects ongoing synaptogenesis, which occurs primarily during the postnatal 
period in mice. For example, mature synapses in visual and somatosensory cortex increase over a 
similar period, from postnatal day 4 to 32 (De Felipe et al., 1997; Li et al., 2010).  
 
In females, PNA treatment increased GABAergic transmission to GnRH neurons by three weeks 
of age, a difference maintained in adulthood. This increase was activity-independent, suggesting 
PNA alters synaptic formation and/or pruning. This observation is consistent with increased 
GABAergic appositions to GnRH neurons in female PNA mice by postnatal day 25 and in adults 
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(Silva et al., 2016). A similar increase in unidentified synaptic contacts to GnRH neurons was 
observed in adult PNA sheep (Kim et al., 1999). An important caveat to the present work is that 
some presynaptic terminals are disassociated from sites of action potential generation in brain 
slices. Likewise, synaptic transmission to GnRH neuron processes that are not preserved within 
the slice cannot be detected. There may thus be additional activity-dependent changes in 
transmission and/or further organizational changes within the whole brain that could not be 
detected.  
 
In addition to effects on neuronal organization, PNA produces mild hyperandrogenemia in adults 
(Sullivan and Moenter, 2004; Witham et al., 2012; Moore et al., 2013). In control mice, gonadal 
biosynthesis of androgens begins around postnatal day five in females and prenatally in males 
(Pointis et al., 1979; Mannan and O'Shaughnessy, 1991); it is not known if this is altered by 
PNA. Mild elevations of androgens such as those observed in PCOS and occur in PNA mice 
upregulate GABA transmission frequency to GnRH neurons (Sullivan and Moenter, 2005), 
although high androgen doses in models of androgen abuse can reduce transmission (Penatti et 
al., 2010; Penatti et al., 2011). Differences in transmission observed in PNA mice could thus be 
attributable to a combination of altered organization and network activation by androgens. It is 
important to point out that prenatal androgen exposure does not merely masculinize GABAergic 
transmission; GABAergic transmission in PNA females is greater than control males in both 
three-week old and adult mice. PNA treatment of males also increases GABAergic transmission 
to GnRH neurons during prepubertal development, further suggesting that prenatal androgen 
exposure has developmental effects separate from sex differences. Unlike females, sPSC 
frequency was not altered by PNA in adult males. This may be attributable to differences in 
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androgen receptor distribution and/or levels at the time of treatment and/or later in development. 
Endogenous androgen levels likely also differ with sex.  
 
In control mice of both sexes, GABA can excite GnRH neurons throughout the age range 
examined in the present studies (DeFazio et al., 2002). GnRH neurons from three-week-old PNA 
mice receive increased GABA transmission compared to controls, but a preliminary report 
indicates their firing activity is reduced at this age (Dulka and Moenter, 2016). This discrepancy 
led us to test the response of GnRH neurons to GABA in female PNA mice. Response in adult 
PNA mice was similar to controls. In marked contrast, cells from three-week-old PNA females 
fired action potentials less often and had blunted membrane depolarization in response to GABA. 
These observations suggest that there are postsynaptic changes in GnRH neurons from PNA 
mice that reduce their firing activity despite increased GABA transmission frequency at this age. 
This is consistent with the observation that neurons can compensate for increased excitatory 
drive to maintain homeostatic activity levels (Davis and Bezprozvanny, 2001).  
 
There are several possible mechanisms by which such compensation may occur. First, PNA may 
alter chloride cotransporter function during development. There was no difference, however, in 
the reversal potential of GABAAR-mediated current between three-week-old control and PNA 
females, suggesting any such changes have minimal perisomatic functional impact. Second, PNA 
may effect voltage-gated sodium channels to modify action potential threshold or increase A-
type potassium currents to reduce neuronal excitability and response to synaptic inputs. Of 
interest with regard to the latter, testosterone increases A-type potassium current to induced 
arterial vasodilation (Ding and Stallone, 2001; Cairrao et al., 2008). Finally, the higher frequency 
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GABAergic input in PNA mice may induce short-term effects, such as shunting inhibition or 
partial inactivation of sodium channels, which would tend to reduce the likelihood of firing. PNA 
did not alter amplitude or kinetics of either mPSCs or sPSCS, suggesting that changes in 
postsynaptic GABAA receptors or number of these receptors activated by endogenous 
presynaptic GABA release do not contribute to the altered response to GABA. Regardless of the 
mechanisms involved in reducing GnRH neuron response to GABA in three-week-old PNA 
mice, these are apparently lost during development or become insufficient to reduce firing as 
there was no effect of PNA on response to GABA in cells from adults. Loss of these adaptive 
mechanisms may be an important factor in upregulating GnRH neuron output in adult PNA mice 
and possibly women with PCOS.  
 
The effects of PNA are most likely dependent upon activation of androgen receptors, as the non-
aromatizable androgen dihydrotestosterone (DHT) was used. In the hippocampus, androgens 
increase synaptic spines (Brawer et al., 1983; Hajszan et al., 2007; Hajszan et al., 2008; 
Hatanaka et al., 2015) and synaptic transmission during pubertal development (Pettorossi et al., 
2013). Additionally, glia express androgen receptor and play key roles in synapse formation and 
regulation (Garcia-Segura et al., 1994; Tasker et al., 2012). Within the hypothalamus, many 
kisspeptin neurons in the arcuate and antereoventral periventricular nuclei are GABAergic 
(Cravo et al., 2011); these cells project to GnRH neurons at least in part to convey steroid 
feedback (Wintermantel et al., 2006). Adult males and females express androgen receptors in 
arcuate and AVPV kisspeptin neurons (Smith et al., 2005; Iwata et al., 2017). In males, this 
expression begins in utero in arcuate neurons but it is unknown when expression begins in 
females (Kumar et al., 2015). The PNA-induced changes in synaptic organization may arise from 
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increased connectivity with typical afferent populations such as those expressing kisspeptin 
and/or recruitment of additional GABAergic afferents. Although the effects of DHT are most 
likely through androgen receptors, we cannot rule out additional effects through activation of 
estrogen receptor ß (ERß) by DHT metabolites (Lund et al., 2006). ERß is expressed in GnRH 
neurons and its activation increases activity in these cells (Hrabovszky et al., 2000; Chu et al., 
2009). 
 
Although there were clear differences in GABAergic transmission to GnRH neurons among 
treatments, frequency was variable particularly in groups with higher frequencies. Both 
biological and technical factors may contribute to this. Differences during development may be 
attributable to variable timing of pubertal maturation in individual mice, and even among cells 
within an animal. The pattern of GABAergic transmission may change over time to help drive 
episodic GnRH release. Typical GnRH release intervals are long compared to the duration of 
recordings and cells may be in different phases when examined, contributing to a range of PSC 
frequencies. GABAergic populations afferent to GnRH neurons may also have different 
sensitivity to programming and/or activational effects of androgens.  
 
Prepubertal development is a critical period during which the changes in GnRH neurons and 
their afferent network may affect the regulation of the reproductive system in adults. The 
increase in GABAergic transmission frequency to these cells and concomitant decrease in their 
responsiveness to GABA that arise before reproductive maturity in PNA females, and the 
subsequent loss of the postsynaptic compensation, may contribute to pathological 
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Chapter 3 Conclusions 
 
Overview 
The GnRH neuronal network is essential for the central regulation of fertility. Dysfunction in this 
network has been implicated in the pathology of polycystic ovary syndrome. The clinical finding 
of altered LH pulsatility in hyperandrogenemic pubertal girls gave rise to our supposition that 
changes in neuroendocrine networks that help regulate reproduction arise during prepubertal 
development. The previous chapter described the postnatal development of GABAergic inputs to 
GnRH neurons before reproductive maturity and demonstrated that prenatal androgenization 
(PNA) and sex uniquely alter GABAergic synaptic connectivity during prepubertal development. 
We further demonstrated that PNA alters GnRH neuron response to GABA during prepubertal 
development in females. These studies have broadened our understanding of the typical 
development of this network in both sexes and begun to explore the mechanisms by which PNA 
may contribute to impaired reproduction in adults. In this chapter, I will discuss further 
interpretations for our findings, particularly in regard to recent clinical and preclinical advances, 
and propose future directions.  
 
GABAergic afferents in the arcuate nucleus may be altered by PNA 
Our work shows that prenatal androgen exposure leads to increased GABAergic synaptic 
transmission to GnRH neurons during prepubertal development in females. These inputs were 
activity-independent, consistent with an increase in synaptic connectivity. An important question 
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to consider in interpreting the implications of these increased connections is where they 
originate. Broadly, increased synaptic release sites may arise from increased connectivity with 
existing afferents and/or through an increased number of GABAergic afferents. The latter case 
encompasses numerous possibilities, including expansion of existing afferent populations or 
recruitment of GABAergic populations that do not typically project to GnRH neurons. The most 
plausible sources for PNA-induced increases in GABAergic connectivity are populations that are 
known to send GABAergic projections to GnRH neurons, are sensitive to androgens and may 
relate to other features of neuroendocrine dysfunction in PNA mice. The arcuate nucleus of the 
hypothalamus is one such credible source. 
 
The arcuate nucleus is considered an important mediator of hormone feedback to GnRH neurons 
and expresses androgen receptors in females (McAbee and DonCarlos, 1998; Yeo and Herbison, 
2014). GABA is widely expressed in the arcuate nucleus and retrograde and anterograde tracing 
studies have demonstrated that GABAergic neurons in the arcuate robustly project to GnRH 
neurons (Moore et al., 2015; Zuure et al., 2016). In adult PNA compared to control females, 
GnRH neurons have increased appositions with GABAergic fibers that specifically originate in 
the arcuate (Moore et al., 2015). This finding implicates the arcuate as a likely source for at least 
some of the increased GABAergic transmission to GnRH neurons in prepubertal PNA mice. 
Interestingly, PNA does not result in any significant change in neuropeptide co-expression with 
GABA in the arcuate (Marshall et al., 2017). Considering this finding, increased GABAergic 
transmission seems less likely to arise from an increase in the number of cells within any 
individual subpopulation of GABAergic neurons in the arcuate and more likely to arise from 
increased number of synaptic release sites with existing GABAergic afferents. Additionally, 
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neuropeptide co-expression was found to differ between sexes and PNA did not induce a more 
masculinized pattern of co-expression, agreeing with our finding that PNA causes 
neuroendocrine changes that are distinct from sex differences (Marshall et al., 2017). While these 
anatomical studies appear to complement our functional studies well, the arcuate is by no means 
the only population of GABAergic afferents to GnRH neurons and transmission from other 
GABAergic afferent populations may be altered by PNA in either prepubertal and/or adult mice. 
 
It is tempting to speculate that GABAergic afferents located in the arcuate overlap with the well 
characterized population of arcuate kisspeptin neurons. These neurons express AR and PR and 
are an important source of input to GnRH neurons (Foradori et al., 2002; Dufourny et al., 2005). 
Recent studies have shown that only 10-15% of arcuate kisspeptin neurons express VGAT, a 
marker of GABAergic neurons (Marshall et al., 2017). This was lower than an earlier report that 
found 50% of arcuate kisspeptin neurons express GAD-67, another marker of GABAergic 
neurons (Cravo et al., 2011). This difference is perhaps due to difficulty of immunodetection of 
kisspeptin peptide compared to using a transgenic reporter. Regardless of the rate of GABA and 
kisspeptin co-expression, only a minority of arcuate kisspeptin neurons actually project to GnRH 
neurons  (Kumar et al., 2015). Although these data indicate that the population of GABAergic 
kisspeptin neurons afferent to GnRH neurons may not be large, it may still be physiologically 
important and could be altered by PNA. However, GnRH neurons in PNA compared to control 
ewes have been shown to have fewer appositions by fibers originating from arcuate kisspeptin 
neurons (Cernea et al., 2015). Furthermore, only 1% of VGAT expressing neurons in the arcuate 
express kisspeptin suggesting that there are likely other GABAergic afferents in the arcuate in 
addition to kisspeptin neurons that could be altered by PNA (Marshall et al., 2017).   
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Alterations in GABA signaling could contribute to neuroendocrine dysfunction seen in PCOS. 
Women with PCOS have elevated levels of GABA in their CSF compared to women with 
normal cycles in the early follicular phase, suggesting that PCOS is associated with altered 
GABAergic signaling (Kawwass et al., 2017). Further evidence suggesting that changes in 
GABA neurotransmission may play a role in the pathogenesis of neuroendocrine dysfunction in 
PCOS is provided by the association between epilepsy and PCOS. The anti-epileptic drug 
valproate increases GABA levels in the brain and may enhance GABAergic transmission 
through presynaptic mechanisms (Preisendorfer et al., 1987; Owens and Nemeroff, 2003). 
Women treated with valproate have increased risk of developing PCOS (Isojarvi et al., 1993; 
Sidhu et al., 2018). Although the mechanisms linking increased GABA levels and PCOS are not 
clear, changes in GABAergic signaling to GnRH neurons could contribute to altered hormone 
feedback in women with PCOS.  
 
Both adult women with PCOS and pubertal girls with hyperandrogenemia have reduced 
sensitivity to progesterone negative feedback (Blank et al., 2009). Female PNA mice have 
similarly reduced sensitivity to progesterone feedback (Moore et al., 2015). The arcuate has been 
shown to be an important site for progesterone negative feedback in rodents and sheep 
(Goodman et al., 2011; He et al., 2017). Progesterone receptor is expressed in GABAergic 
arcuate neurons and GABA may help mediate progesterone feedback to GnRH neurons in mice 
(Leranth et al., 1992; Sullivan and Moenter, 2005). Expression of progesterone receptor is 
reduced in PNA mice, most notably, but not exclusively, in the arcuate nucleus (Moore et al., 
2015). The mechanism by which PNA may alter GABAergic neurons in the arcuate to decrease 
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progesterone receptor expression and increase appositions to GnRH neurons is not clear. 
Together, increased GABAergic transmission and reduced sensitivity to suppression by 
progesterone feedback are potential drivers of increased GnRH neuron activity women and girls 
with PCOS.  
 
Projections from neurons in the arcuate nucleus have been shown to develop postnatally in mice 
(Bouret et al., 2004). Tracing of arcuate neuron axons showed that innervation of the medial 
preoptic area does not reach mature levels until two weeks of age (Bouret et al., 2004). 
Formation of functional synapses likely follows the first appearance of axonal projections. The 
timing of the development of efferent projections from the arcuate is interesting firstly, because 
it mirrors the timing of development of GABAergic transmission to GnRH neurons in control 
females and secondly because if arcuate neuron projections to GnRH neurons are altered by PNA 
it would help explain our observation that PNA does not increase the frequency of activity-
independent GABAergic transmission to GnRH neurons until three-weeks of age. Although the 
density of labeled axonal fibers did not change between two weeks of age and adulthood, there 
could still be changes in synaptic connectivity due to increased formation or pruning of the 
number of synaptic release sites (Chan et al., 2011). Although the study by Bouret et al. did not 
specifically examine GABAergic arcuate neurons, it shows that development of synaptic 
innervation from the arcuate nucleus likely occurs at least to some degree during prepubertal 
development. In order to determine if the altered GABAergic transmission that emerges during 
this time is dependent on concomitantly elevated androgen levels we could treat PNA and 
control mice with a placebo or an androgen receptor antagonist such as flutamide and determine 
if this ameliorates changes with PNA.  
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GABAergic transmission is not the only source of excitatory input to GnRH neurons. 
Glutamatergic neurons also provide fast-synaptic transmission to GnRH neurons (Ottem et al., 
2002; Christian et al., 2009) and may be altered by PNA either in prepubertal and/or adult mice. 
GnRH neurons from adult PNA mice do not have an increase in the density or number of 
dendritic spines with close appositions with glutamatergic fibers (Moore et al., 2015), however 
PNA may program differences in activity-dependent synaptic transmission during development 
and/or adulthood. The timing of development of glutamatergic transmission to GnRH neurons is 
not known nor is it known if PNA changes glutamatergic synaptic connectivity during 
prepubertal development. A decrease in glutamatergic EPSCs, alone or in combination with 
GnRH neuron intrinsic changes, could in part contribute to decreased GnRH neuron firing at 
three-weeks of age (Dulka and Moenter, 2016). Future studies could examine the frequency and 
amplitude of glutamatergic currents in control and PNA females at three-weeks of age and in 
adults to determine if changes in the glutamatergic afferent neuronal network may play a role in 
altered GnRH neuron activity in PNA mice. Additional aspects of the GnRH afferent neuronal 
network that could be altered by PNA include non-GABAergic, non-glutamatergic kisspeptin 
neurons in the arcuate and/or AVPV nuclei. For example, anatomical tracing studies could be 
used to examine if PNA changes the density of kisspeptin projections near GnRH neurons or 
functional studies could be used to measure if PNA changes kisspeptin release in the area of 
GnRH neurons or their projections to the median eminence.  
 
The effects of androgens may be mediated by different populations such as glutamatergic, 
GABAergic and/or kisspeptidergic neurons that project directly and indirectly to GnRH neurons. 
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To better understand how each of these populations may contribute to the effects of PNA, future 
studies could selectively remove androgen receptor from each of these cell types in control and 
PNA mice and measure if AR receptor knock out in a given population is sufficient to blunt or 
diminish the changes induced by PNA. This would give more targeted information than global 
AR knock out or systemic treatment with an androgen receptor antagonist such as flutamide. 
Two approaches could be used to delete androgen receptor from specific populations of interest. 
First, floxed AR transgenic mice could be crossed with cell type specific CRE transgenic mice, 
such as VGAT CRE mice. This approach would allow for a AR to be knocked out in a high 
percentage of GABAergic cells but would likely include cells that are not part of the GnRH 
afferent network. In the case of GABA, AR would primarily be knocked out centrally rather than 
in the gonads and elsewhere. Kisspeptin, however, has been shown to be expressed outside of the 
brain and these cells may also theoretically express AR. Furthermore, this knock out would occur 
before birth rather than specifically examining androgen receptor-dependent effects during 
prepubertal development.  
 
To refine our understanding of the effects of AR signaling in different aspects of the GnRH 
neuronal network a second, more spatially and temporally targeted approach could be used. 
Floxed AR transgenic mice could be injected with an AAV-CRE virus to specific nuclei of 
interest and at different times during postnatal development, potentially as early as three weeks 
of age. Notably, this approach would not be selective for specific cell types but would target all 
AR-expressing cells in a nucleus. This approach would have several advantages, particularly as a 
followup to the first approach, in that it would allow for knock out of AR in specific nuclei 
known to project to GnRH neurons, such as the arcuate. This approach could also be used to 
 75 
target AR in other nuclei that express GABA such as those that contain populations of AGRP or 
POMC neurons. It is likely that AR expression would be knocked down but not deleted entirely 
which is desirable since it would be more physiologically comparable to the relative difference in 
androgen exposure in control and PNA mice. Reproductive outcomes to be compared could 
include vaginal opening, first estrous, fertility and estrous cycle characteristics.  
 
Interesting future studies could also expand our understanding of the development of 
GABAergic transmission to GnRH neurons. Our studies were done in coronal brain slices in 
which afferent cell bodies that are not in the slice are separated from their synaptic terminals. 
Alternative slice orientations could be used to preserve intact connections with afferents in the 
arcuate nucleus or elsewhere. Another limitation to this work is that it is difficult to maintain a 
stable whole-cell recording configuration for long periods of time. Recordings of GnRH neuron 
firing rates last for minutes to hours while recordings of PSCs rarely last more than 30 minutes 
and are sometimes less than 10 minutes (following stabilization). Longer recordings could reveal 
if there are changes in transmission frequency or amplitude that occur over time and give us a 
more complete picture of the function of the afferent network to GnRH neurons. Additionally, 
the pattern of PSCs, not only the frequency itself, may be important to determining the effect of 
inputs on cell firing and/or GnRH release.  
 
Potential mechanisms of decreased GnRH neuron response to GABA in prepubertal PNA 
mice 
A recent paper from our lab demonstrated that GnRH neuron firing rates are decreased in PNA 
mice at 3-wks of age, despite increase in GABAergic transmission (Dulka and Moenter, 2016). 
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This contrasts with PNA adults in which increased GABAergic transmission frequency is 
associated with increased GnRH neuron firing rate (Roland and Moenter, 2011). We showed that 
GnRH neurons from three-week old, but not adult, PNA mice have reduced membrane potential 
depolarization in response to GABA and are less likely to fire in response to GABA. The blunted 
membrane potential response to GABA in GnRH neurons from prepubertal PNA mice may 
indicate that PNA induces changes in the responsiveness of GnRH neurons to GABAAR 
activation. GABA receptor subtypes may change during prepubertal development (Sim et al., 
2000) and PNA could alter the expression of different GABA receptor subtypes or alter their 
binding affinity, duration of ion channel opening or the open probability of the ion channel. In 
addition to GABAAR on the postsynaptic membrane of GnRH neurons, synaptic glial cells are 
important for rapidly clearing the high concentrations of GABA in the synaptic cleft (Gadea and 
Lopez-Colome, 2001; Tasker et al., 2012). Glial cells express AR and could theoretically be 
altered to clear GABA more or less efficiently (Garcia-Ovejero et al., 2002). However, such 
changes were not indicated by our data as we did not observe any changes in PSC amplitude or 
decay time. We hypothesized that PNA could alter chloride homeostasis during development as a 
mechanism to explain the change in membrane depolarization in response to GABA. However, 
we did not observe any differences in the equilibrium potential of GABAAR-associated current 
between control and PNA prepubertal mice. Furthermore, the GABAAR equilibrium potentials 
measured in prepubertal mice were no different from adults in either control or PNA groups and 
no different from previously published adult values (unpublished data).  
 
The change in firing response to GABA may be explained by other changes in the intrinsic 
properties of GnRH neurons. Intrinsic properties refer to the expression and activity of ion 
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channels and transporters that help determine the basal membrane potential and membrane 
potential changes of a neuron in response to current. In prepubertal PNA mice, changes in 
intrinsic properties could underlie the altered response to GABA and/or contribute to increased 
synaptic connectivity through altered synaptic refinement (i.e., stabilization and/or pruning). 
Regardless of the mechanism, intrinsic changes may contribute to altered function of GnRH 
neurons and their network in prepubertal PNA mice. Intrinsic properties that could be altered by 
PNA include excitability and action potential properties. Excitability is measured as the minimal 
current necessary to induce firing and the number of spikes generated by depolarizing current 
steps. Action potential properties include the latency to fire between the start of a current 
injection to the first spike, the spike amplitude and full width at half maximum (FWHM), spike 
rate of rise, firing threshold and amplitude of the after hyperpolarization (AHP). Decreased 
excitability, increased latency to fire and depolarization of the firing threshold could all 
contribute to the decreased firing response to GABA in GnRH neurons in prepubertal PNA mice. 
If such developmental changes in excitability and action potential properties exist in prepubertal 
PNA mice such differences either don’t persist into adulthood or are overcome by increased 
excitatory inputs to result in increased GnRH neuron firing. GnRH neuron intrinsic properties 
have not been studied during pubertal development or in PNA mice at any stage of development.  
 
Effects of PNA on GnRH neuron intrinsic properties could be mediated by subthreshold currents. 
A-type potassium currents as well as calcium currents are important for determining excitability 
and action potential properties in GnRH neurons and are modulated by steroid hormone feedback 
in adults (DeFazio and Moenter, 2002). A-type potassium current may be activated by small 
membrane depolarizations in response to GABAergic transmission. Increased A-type potassium 
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current by PNA could prevent further depolarization to threshold and thus limit firing in response 
to GABA.  
 
Effects of testosterone treatment in female-to-male transgender adolescents 
Gender dysphoria is a condition in which the gender assigned at birth is incongruent with the 
individual’s self-perception of their gender (Wiepjes et al., 2018). Testosterone replacement is an 
important aspect of gender-affirming treatment for transgender males (female-to-male, FTM). 
Testosterone is administered in doses sufficient to achieve serum levels within the normal 
physiologic range for males (Hembree et al., 2017). This treatment is continued long-term to 
induce and maintain virilization of secondary sex characteristics (den Heijer et al., 2017). 
Although the availability and access to health care professionals who are appropriately trained 
and willing to care for transsexual individuals has increased over the last several decades, the 
impact of testosterone treatment on the hypothalamic-pituitary-ovarian axis has not been well 
studied in this population.  
 
Multiple studies in female-to-male transsexuals have shown that testosterone treatment results in 
morphological changes in the ovaries similar to changes seen in PCOS (Futterweit and 
Deligdisch, 1986; Spinder et al., 1989; Grynberg et al., 2010). The majority of these patients had 
complete cessation of regular menses. However, these studies were done on adults with a wide 
range in both age and duration of treatment. Treatment of adult (6-13 years of age) rhesus 
monkeys for only 10 days resulted in enhanced ovarian follicle growth, suggesting that ovarian 
changes may begin relatively early after treatment initiation (Vendola et al., 1998). The effects of 
testosterone treatment may depend on when therapy is initiated relative to the pubertal transition. 
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As discussed previously, exposure to androgens, particularly during development, may play a 
role in the pathogenesis of PCOS (Burt Solorzano et al., 2010). Interestingly, three-week old 
female rats treated with DHEAS for two weeks developed ovarian cysts (Anderson et al., 1992; 
Honnma et al., 2006). Currently the standard of care for treatment of FTM individuals in early 
adolescence is to administer GnRH agonists i.e., ‘puberty blockers’ at the initiation of puberty 
(Tanner stage 2) and to begin testosterone treatment at around age 16 while they are still 
biologically in the early stages of puberty (Hembree et al., 2017). While some features of clinical 
hyperandrogenemia are desirable in these patients, such as male-pattern hair growth, other 
aspects of PCOS, including the associated metabolic syndrome, would be detrimental. Even if 
testosterone therapy does not induce PCOS in FTM transsexuals, it could exacerbate symptoms 
in those with underlying PCOS or susceptibility to PCOS and potentially worsen metabolic 
features. Additionally, medical professionals have historically assumed that these individuals had 
no desire for fertility, however there is emerging understanding that many of these individuals do 
desire to have their own children. The possible association between adolescent androgen 
exposure and PCOS should be further explored so that patients can be appropriately counseled 
on the risks and benefits of initiating testosterone therapy. 
 
Final conclusions 
Exposure to androgens during development has been shown to result in an adult phenotype that 
recapitulates features of PCOS and our work adds to our understanding that this effect may be in 
part mediated through androgen effects on prepubertal development of neuronal networks 
afferent to GnRH neurons. Development of a PCOS-like phenotype in adult PNA mice is 
dependent on neuronal expression of androgen receptor suggesting that early androgen exposure 
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directly impacts developing neuronal networks (Caldwell et al., 2017). In young pubertal female 
mice, exposure to an aromatase inhibitor, Letrozole, is sufficient to recapitulate neuroendocrine 
features of PCOS including altered gonadotropin secretion and reduced progesterone receptor 
expression (Kauffman et al., 2015).  
 
Childhood obesity and its associated hyperandrogenemia may be a predisposing factor for 
developing PCOS and/or increase the severity of PCOS in adolescence (Anderson et al., 2014). 
Overweight peripubertal girls have increased androgens from both adrenal and ovarian sources 
(Burt Solorzano et al., 2017). Prepubertal androgen exposure, regardless of the source, may alter 
gonadotropin secretion and promote further excess androgen production. Obesity in peripubertal 
girls may therefore create a vicious cycle of neuroendocrine dysfunction and 
hyperandrogenemia. Impaired reproductive function may therefore be yet another comorbidity of 
the childhood obesity epidemic. Increasing our understanding of the role of pubertal 
development in the pathogenesis of PCOS will create greater opportunities for earlier 
intervention and management of PCOS symptoms.  
 
Although precursors to PCOS have been established to emerge before pubertal maturation, the 
difficulty in diagnosing PCOS in early pubertal girls results in treatment being delayed until later 
in adolescence when the diagnosis can be well established. Hyperandrogenemia may be the 
earliest clinically useful indicator of the risk of developing PCOS in adolescents. Postmenarchal 
girls have irregular cycles with frequent anovulatory cycles for several years following menarche 
(Knudsen et al., 2010; Shayya and Chang, 2010). Polycystic ovaries are not recommended as a 
diagnostic feature for PCOS in adolescents as advances in ultrasound technology have made 
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possible the realization that PCO is a common finding in young women (Kristensen et al., 2010). 
Furthermore, transabdominal ultrasound is less sensitive in obese patients and transvaginal 
ultrasound is not appropriate for the evaluation of young pubertal girls, particularly those who 
are not sexually active. Interventions aimed at identifying and decreasing excess androgen levels 
in obese prepubertal girls may be a strategy for PCOS prevention.  
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